Seoul National University Hospital
Seoul, 110-744, South Korea
NCT Number: NCT01542905
The purpose of this study is to examine clinical and neuropsychiatric effects of Korean Red Ginseng and examine changes in brain structure, function and metabolites. A total of 60 healthy volunteers will be recruited and will be assigned to either Korean Red Ginseng group or placebo group. Individuals will be examined through clinical assessment, neuropsychological function tests and neuroimaging.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Seoul, 110-744, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Korean Red Ginseng Capsule (1g/day) for 8 Weeks
Placebo Capsule (1g/day) for 8 Weeks
Time frame: Baseline and 8 Weeks
Time frame: Baseline and 4 Weeks
Time frame: Baseline and 1 Week
Time frame: Baseline and 8 Weeks
Time frame: Baseline and 8 Weeks
Time frame: Baseline and 8 Weeks
Time frame: Baseline and 4 Weeks
Time frame: Baseline and 1 Week
Time frame: Baseline and 8 Weeks
Time frame: Baseline and 4 Weeks
Time frame: Baseline and 1 Week
Time frame: Baseline and 8 Weeks
Time frame: Baseline and 4 Weeks
Time frame: Baseline and 1 Week
Time frame: Week 1
Time frame: Week 4
Time frame: Week 8
Seoul National University Hospital
Other
Effects of Korean Red Ginseng on Stress Relief and Cognitive and Mental Function Enhancement Using Neuroimaging: Double-Blind, Randomized, Placebo-Controlled Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.